Therefore, altering metabolic changes might be a key to developing joint-protective strategies in RA-FLSs (64) and more research is required to decipher the complex network of HAPLN1 functions contributing to the altered metabolic status of RA-FLSs. This evidence concerns the gene HAPLN1 and rheumatoid arthritis.